About JALM

With JALM, the Association for Diagnostics & Laboratory Medicine (ADLM) empowers lab professionals to discover new adaptive solutions to patient health problems and drive innovation in the field. JALM expands on the scope of cutting-edge research in Clinical Chemistry by focusing on translational or applied laboratory medicine studies.

JALM considers submissions on laboratory methods and practice, evidence-based laboratory medicine and related clinical topics, clinical chemistry (including toxicology and therapeutic drug monitoring), and more. Additionally, it provides a forum for discussion of policy and regulatory issues that impact the field.

JALM is a fully open access journal. Visit the open access page for details. ADLM Professional members who are the corresponding author of a paper accepted by JALM receive a discount on open access fees as a member benefit.

The effects of the Duffy-Null genotype on medication

Adjusted absolute neutrophil count reference ranges reduced the number of patients classified as abnormal. 

A close-up of DNA strands for research analysis.

More precise troponin testing

New data show high sensitivity, precision, and interference resistance.

A ribbon diagram of the human cardiac troponin core complex.
Further Reading